EYPT
Eyepoint Pharmaceuticals Inc
3.30$
+4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 48.4 | 145.7 | 443.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.0 | 4.8 | 7.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 45.3 | 135.8 | 405.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -16.0% | -24.5% | -21.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -923.1% | -104.8% | -100.7% | -35.7% | 15.1% | -191.0% | -157.7% | -317.4% | -507.2% | -304.8% | -174.2% | 5.8% | 60.9% | 86.8% | 87.1% | 86.2% | 87.0% | 83.1% | 81.8% | 80.4% | 76.6% | 77.9% | 78.0% | 79.8% | 81.3% | 79.9% | 81.9% | 80.6% | 83.4% | 89.9% | 90.5% | 91.3% | 91.5% | 91.4% | 93.3% | 95.1% | 94.1% | 93.4% | 76.5% | 41.8% | |
| -1,675.5% | -273.9% | -264.6% | -246.4% | -227.5% | -885.8% | -767.8% | -887.3% | -1,104.6% | -318.7% | -434.0% | -205.1% | -179.4% | -235.0% | -172.8% | -200.6% | -93.3% | -108.3% | -107.3% | -93.5% | -153.6% | -149.6% | -161.0% | -170.9% | -174.3% | -240.6% | -258.6% | -285.1% | -240.9% | -163.1% | -173.6% | -195.7% | -255.9% | -337.1% | -287.9% | -364.3% | -515.7% | -776.0% | -3,700.9% | -11,365.2% | |
| -1,661.5% | -271.3% | -262.6% | -245.2% | -226.3% | -882.4% | -843.5% | -1,795.7% | -2,622.9% | -1,884.2% | -1,739.8% | -621.0% | -409.1% | -278.9% | -196.3% | -229.3% | -112.2% | -131.8% | -129.8% | -106.1% | -167.4% | -158.1% | -172.5% | -184.5% | -184.4% | -247.0% | -257.4% | -283.8% | -235.5% | -153.8% | -157.8% | -172.3% | -226.6% | -302.4% | -261.9% | -337.9% | -486.0% | -739.4% | -3,566.6% | -10,994.7% | |
| -1,286.6% | -294.2% | -286.4% | -273.7% | -263.9% | -779.3% | -698.8% | -747.8% | -913.9% | -736.4% | -749.1% | -439.2% | -397.0% | -279.5% | -231.2% | -210.0% | -89.0% | -43.0% | -39.5% | -48.4% | -85.7% | -136.0% | -142.5% | -154.9% | -166.6% | -162.2% | -161.3% | 31.6% | 21.7% | -3.5% | -33.3% | -187.3% | -258.2% | -301.1% | -270.0% | -373.9% | -504.5% | -775.8% | -3,565.9% | -9,726.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -164.6% | -126.4% | -149.9% | -138.6% | -192.3% | -232.4% | -303.2% | -455.0% | -168.4% | -228.9% | -495.0% | -267.5% | -363.8% | -681.8% | -307.9% | -1,246.0% | -531.1% | -244.8% | -38.5% | -38.9% | -58.7% | -31.7% | -40.2% | -50.5% | -57.4% | -106.1% | -130.7% | -185.0% | -170.8% | -26.6% | -31.6% | -38.0% | -47.3% | -38.9% | -49.2% | -71.3% | -102.8% | -75.8% | -117.8% | -184.3% | |
| -95.4% | -94.5% | -107.1% | -99.0% | -129.9% | -162.2% | -49.6% | -74.2% | -90.4% | -110.2% | -120.2% | -82.6% | -73.3% | -77.8% | -63.2% | -74.9% | -52.5% | -49.5% | -23.8% | -23.2% | -32.4% | -22.2% | -27.4% | -32.8% | -35.5% | -56.7% | -66.3% | -60.3% | -62.6% | -19.9% | -24.0% | -26.8% | -34.4% | -31.3% | -40.5% | -58.2% | -81.7% | -63.7% | -94.2% | -134.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -14 | -12 | -13 | -17 | -12 | -13 | 9.4 | -4.2 | -38 | -28 | -11 | 2.5 | 15 | 25 | 26 | 28 | 29 | 1.5 | -95 | -82 | -72 | -141 | -62 | -42 | -35 | -55 | -71 | -139 | -132 | -281 | -270 | -90 | -79 | -98 | -83 | – | -73 | -100 | -76 | -108 | |
| 57.9% | 74.8% | 71.5% | 71.4% | 67.5% | 69.8% | 16.3% | 16.3% | 53.7% | 48.1% | 24.3% | 30.9% | 20.2% | 11.4% | 20.5% | 6.0% | 9.9% | 20.2% | 61.8% | 59.8% | 55.1% | 70.0% | 68.2% | 64.8% | 61.8% | 53.4% | 50.7% | 32.6% | 36.6% | 75.0% | 75.9% | 70.4% | 72.7% | 80.4% | 82.3% | 81.7% | 79.5% | 84.1% | 80.0% | 72.9% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.1 | 3.0 | 0.4 | 0.5 | 1.6 | 1.7 | 3.0 | 5.7 | 3.2 | 12.1 | 7.6 | 2.5 | 0.4 | 0.4 | 0.5 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -6.96 | -5.46 | -5.46 | -4.78 | -4.39 | -5.17 | -5.45 | -9.60 | -10.68 | -9.07 | -10.31 | -7.10 | -5.42 | -5.32 | -4.39 | -4.18 | -3.15 | -3.13 | -1.80 | -1.45 | -1.89 | -1.79 | -1.80 | -2.05 | -2.10 | -2.74 | -2.73 | -2.82 | -2.61 | -1.68 | -1.49 | -1.63 | -1.90 | -2.03 | -2.10 | -2.51 | -2.93 | -2.79 | -3.16 | -3.54 | |
| 0.42 | 2.01 | 2.08 | 1.95 | 1.94 | 0.59 | 0.65 | 0.53 | 0.41 | 0.48 | 0.59 | 1.14 | 1.33 | 1.91 | 2.24 | 1.82 | 2.81 | 2.37 | 1.39 | 1.36 | 1.13 | 1.13 | 1.04 | 1.11 | 1.14 | 1.11 | 1.06 | 0.99 | 1.11 | 1.09 | 0.95 | 0.95 | 0.84 | 0.67 | 0.80 | 0.74 | 0.60 | 0.38 | 0.09 | 0.03 | |
| 4.23 | 4.32 | 3.64 | 3.45 | 2.28 | 2.22 | 1.80 | 2.11 | 6.35 | 3.96 | 2.08 | 2.66 | 1.49 | 0.78 | 1.43 | 0.34 | 0.59 | 1.28 | 4.68 | 3.72 | 3.22 | 5.64 | 4.48 | 4.06 | 3.65 | 2.58 | 2.09 | 1.52 | 1.53 | 6.32 | 4.72 | 4.29 | 4.02 | 5.21 | 4.28 | 3.52 | 2.85 | 3.69 | 2.68 | 1.92 | |
| -5.39 | -5.92 | -5.95 | -5.34 | -5.12 | -4.57 | -4.51 | -4.00 | -3.72 | -3.55 | -4.44 | -5.02 | -5.26 | -5.33 | -5.17 | -3.83 | -2.50 | -1.02 | -0.55 | -0.66 | -0.97 | -1.54 | -1.49 | -1.72 | -1.89 | -1.80 | -1.71 | 0.31 | 0.24 | -0.04 | -0.31 | -1.77 | -2.17 | -2.02 | -2.17 | -2.77 | -3.04 | -2.93 | -3.16 | -3.13 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.